Combat Medical raises £2.6 million Series A to advance treatment of BCG unresponsive bladder cancer
Combat Medical (Combat), a medical device company optimizing the delivery and efficacy of cancer therapeutics, today announced it has raised £2.6 million in the first close of a Series A…